Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Onchocerciasis
Clinical trial NCT03876262 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03876262
- Sponsor
- Medicines Development for Global Health
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-03
- Primary completion
- 2024-07-31
- Enrollment
- 323
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.